J Evid Based Dent Pract:洗必泰和聚维酮碘漱口水可有效杀灭唾液中SARS-CoV-2

2021-10-14 MedSci原创 MedSci原创

口腔是COVID-19的潜在高风险传播环境。抗菌漱口水用于许多临床手术之前,以减少牙科环境中交叉感染的风险。研究漱口水杀灭唾液中SARS-CoV-2的功效十分重要,以减少牙科团队在牙科手术中的暴露。近

口腔是COVID-19的潜在高风险传播环境。抗菌漱口水用于许多临床手术之前,以减少牙科环境中交叉感染的风险。研究漱口水杀灭唾液中SARS-CoV-2的功效十分重要,以减少牙科团队在牙科手术中的暴露。近日,发表于J Evid Based Dent Pract的随机试验旨在评估2种术前漱口水对减少唾液中SARS-CoV-2病毒量的效果。

在这项随机对照的临床试验中,研究纳入鼻咽拭子证实的COVID-19阳性患者。参与者被分为3组:30秒内,对照组用蒸馏水漱口,洗必泰组用0.2%洗必泰漱口,聚维酮碘组用1%聚维酮碘漱口。漱口前和漱口后5分钟收集唾液样本。然后对每个样本进行SARS-CoV-2 rRT-PCR检测。

 

结果,共纳入61名符合要求的参与者(36名女性和25名男性),平均年龄为45.3±16.7岁。蒸馏水组和0.2%洗必泰(P=0.0024)及1%聚维酮碘(P=0.012)这两种溶液的delta Ct之间存在明显差异。使用0.2%洗必泰和1%聚维酮碘溶液的患者的δCt值没有发现明显差异(P = .24)。在洗必泰组(n = 27)和聚维酮碘组(n = 25)的配对样本之间发现了显著的平均Ct值差异(P < .0001)(P < .0001)。相比之下,对照组(n = 9)在实验前后没有明显差异(P = .566)。

综上所述,该研究结果表明,0.2%洗必泰和1%聚维酮碘口服液是预防牙科治疗中唾液传播SARS-CoV-2的有效术前漱口液,应考虑将其作为一种预防策略,以减少COVID-19在牙科治疗过程中的传播。

 

原始出处:

 

Rola Elzein, et al., In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial. J Evid Based Dent Pract. 2021 Sep;21(3):101584. doi: 10.1016/j.jebdp.2021.101584.  

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1764811, encodeId=ccdb1e6481136, content=<a href='/topic/show?id=2eab650862c' target=_blank style='color:#2F92EE;'>#洗必泰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65086, encryptionId=2eab650862c, topicName=洗必泰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae237803097, createdName=1696533704_45270466, createdTime=Thu Dec 16 05:47:20 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938047, encodeId=32af193804e95, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Thu Aug 25 20:47:20 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064437, encodeId=d683106443e73, content=有指导价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Wed Oct 27 18:16:20 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321315, encodeId=5c471321315cd, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369792, encodeId=d5e91369e92c7, content=<a href='/topic/show?id=dd26666594b' target=_blank style='color:#2F92EE;'>#漱口水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66659, encryptionId=dd26666594b, topicName=漱口水)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d98302, createdName=wolongzxh, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1764811, encodeId=ccdb1e6481136, content=<a href='/topic/show?id=2eab650862c' target=_blank style='color:#2F92EE;'>#洗必泰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65086, encryptionId=2eab650862c, topicName=洗必泰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae237803097, createdName=1696533704_45270466, createdTime=Thu Dec 16 05:47:20 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938047, encodeId=32af193804e95, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Thu Aug 25 20:47:20 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064437, encodeId=d683106443e73, content=有指导价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Wed Oct 27 18:16:20 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321315, encodeId=5c471321315cd, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369792, encodeId=d5e91369e92c7, content=<a href='/topic/show?id=dd26666594b' target=_blank style='color:#2F92EE;'>#漱口水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66659, encryptionId=dd26666594b, topicName=漱口水)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d98302, createdName=wolongzxh, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=)]
    2022-08-25 hukaixun
  3. [GetPortalCommentsPageByObjectIdResponse(id=1764811, encodeId=ccdb1e6481136, content=<a href='/topic/show?id=2eab650862c' target=_blank style='color:#2F92EE;'>#洗必泰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65086, encryptionId=2eab650862c, topicName=洗必泰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae237803097, createdName=1696533704_45270466, createdTime=Thu Dec 16 05:47:20 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938047, encodeId=32af193804e95, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Thu Aug 25 20:47:20 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064437, encodeId=d683106443e73, content=有指导价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Wed Oct 27 18:16:20 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321315, encodeId=5c471321315cd, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369792, encodeId=d5e91369e92c7, content=<a href='/topic/show?id=dd26666594b' target=_blank style='color:#2F92EE;'>#漱口水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66659, encryptionId=dd26666594b, topicName=漱口水)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d98302, createdName=wolongzxh, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=)]
    2021-10-27 薛鹏

    有指导价值

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1764811, encodeId=ccdb1e6481136, content=<a href='/topic/show?id=2eab650862c' target=_blank style='color:#2F92EE;'>#洗必泰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65086, encryptionId=2eab650862c, topicName=洗必泰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae237803097, createdName=1696533704_45270466, createdTime=Thu Dec 16 05:47:20 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938047, encodeId=32af193804e95, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Thu Aug 25 20:47:20 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064437, encodeId=d683106443e73, content=有指导价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Wed Oct 27 18:16:20 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321315, encodeId=5c471321315cd, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369792, encodeId=d5e91369e92c7, content=<a href='/topic/show?id=dd26666594b' target=_blank style='color:#2F92EE;'>#漱口水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66659, encryptionId=dd26666594b, topicName=漱口水)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d98302, createdName=wolongzxh, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=)]
    2021-10-16 小刀医生
  5. [GetPortalCommentsPageByObjectIdResponse(id=1764811, encodeId=ccdb1e6481136, content=<a href='/topic/show?id=2eab650862c' target=_blank style='color:#2F92EE;'>#洗必泰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65086, encryptionId=2eab650862c, topicName=洗必泰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae237803097, createdName=1696533704_45270466, createdTime=Thu Dec 16 05:47:20 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1938047, encodeId=32af193804e95, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Thu Aug 25 20:47:20 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064437, encodeId=d683106443e73, content=有指导价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Wed Oct 27 18:16:20 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321315, encodeId=5c471321315cd, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369792, encodeId=d5e91369e92c7, content=<a href='/topic/show?id=dd26666594b' target=_blank style='color:#2F92EE;'>#漱口水#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66659, encryptionId=dd26666594b, topicName=漱口水)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d98302, createdName=wolongzxh, createdTime=Sat Oct 16 05:47:20 CST 2021, time=2021-10-16, status=1, ipAttribution=)]

相关资讯

NEJM:腮腺导管喷出的唾液-病例报道

挤压这些区域导致双侧导管口大量唾液排出,腮腺管的开口位于上颌第二磨牙附近颊(颊)粘膜。颈部计算机断层扫描发现双侧腮腺管沿导管扩张,未发现阻塞原因。

J Clin Periodontol:唾液IL-1β水平用于估计非吸烟者和吸烟者牙周炎发生概率的准确性

本文检测唾液白细胞介素(IL)1β水平,通过吸烟习惯进行区分,并基于模型预测牙周炎的发生概率。

Lancet Infect Dis: 唾液中2019-nCOV的检测及COVID-19患者的口腔症状

由一种新的冠状病毒(2019-NCOV)引起的冠状病毒疾病19(Covid-19)已被世界卫生组织(WHO)归类为大流行病。 据报道,2019-NCOV可以在各种人类分泌和排泄物中检测到,如痰、粪便和

IBD:炎症性肠病患者唾液和血清的炎症特征不一致

炎症性肠病(IBD),包括克罗恩病(CD)和溃疡性结肠炎(UC)。它是一组慢性免疫介导的炎症性疾病,影响了全球超过350万人。患者不光可以再肠道

Behavioural Brain Research:同情心和工作资源可以缓解较高工作要求的护理人员唾液α淀粉酶催化反应增加

工作需求资源(JD-R)模型很少与压力和不良健康的生理指标结合使用。这项研究探索了JD-R模型与压力反应生理指标之间的关联,同时考虑了这种关系的潜在调节因素。